ORMP stock

Oramed Pharmaceuticals Inc (ORMP) financials · $87.2M cap

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Oramed Pharmaceuticals Inc (ORMP) $87.2M cap.

Cached income statement (latest stored periods)
LineQ2 2026Q1 2026
Operating Income-$2.77M-$3.66M
Net Income$78.2M$38.3M
EPS (Diluted)$1.84$0.91
Cached balance sheet (latest stored periods)
LineQ2 2026Q1 2026
Total Assets$369.6M$268.8M
Current Assets$53.4M$68.2M
Cash & Equivalents$15.2M$13.2M
PP&E$532.0K$561.0K
Total Liabilities$52.2M$30.6M
Current Liabilities$10.7M$10.6M
Shareholders' Equity$317.5M$238.3M
Retained Earnings-$6.96M-$85.1M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$9.14M-$8.41M
CapEx$9.00K$18.0K
Investing Cash Flow$5.44M$105.8M
Financing Cash Flow-$4.74M-$52.0M
Net Change in Cash-$8.47M$45.4M
Free Cash Flow-$9.15M-$8.43M
These statements as JSON? API free 100/day

FAQ

What is ORMP P/E and revenue?

Oramed Pharmaceuticals Inc (ORMP) $87.2M cap.

What is ORMP revenue?

ORMP income-statement cache has no revenue figure yet.

Is ORMP profitable?

Oramed Pharmaceuticals Inc last cached net income is $78.2M (Q2 2026).

What are ORMP total assets?

Oramed Pharmaceuticals Inc last cached total assets are $369.6M (Q2 2026).

What is ORMP free cash flow?

Oramed Pharmaceuticals Inc last cached free cash flow is -$9.15M (FY2025).

Not investment advice. Cached statements, not a live tape.